tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
Recro Pharma's activity chart (see below) currently has 23 price targets and 20 ratings on display.
Analysts average stock forecasts to be materialized ratio is 51.82% with an average time for these price targets to be met of 175.82 days.
Most recent stock forecast was given by MATT HEWITT from CRAIG HALLUM on 04-Jan-2021. First documented stock forecast 16-Sep-2016.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 04-Jan-2021
$6
$5.21 (659.49%)
5 years 8 months 28 days ago
(04-Jan-2021)
0/1 (0%)
$2.91 (94.17%)
Buy
$5
$4.21 (532.91%)
$18
6 years 1 months 21 days ago
(11-Aug-2020)
2/4 (50%)
$3.59 (41.69%)
106
Buy Since 16-Oct-2019
$5
$4.21 (532.91%)
$18
6 years 1 months 21 days ago
(11-Aug-2020)
2/4 (50%)
$1.8 (56.25%)
106
Buy Since 12-May-2020
$12
$11.21 (1418.99%)
$18
6 years 4 months 20 days ago
(12-May-2020)
3/6 (50%)
$7.12 (145.90%)
146
Buy Since 19-Dec-2016
6 years 10 months 6 days ago
(26-Nov-2019)
3/3 (100%)
$2.32 (40.35%)
197
What is REPH (Recro Pharma) average time for price targets to be met?
Which analyst most recently updated their price target on REPH (Recro Pharma)?
Which analyst has the most public recommendations on REPH (Recro Pharma)?
Which analyst is the currently most bullish on REPH (Recro Pharma)?
Which analyst is the currently most reserved on REPH (Recro Pharma)?
